 |
Current trends in non-surgical facial rejuvenation: Aesthetic outcomes and safety
Third Year MBBS Student, University College of Medicine and Dentistry, Pakistan
Citation tools:
Copyright information
© Our Dermatology Online 2026. No commercial re-use. See rights and permissions. Published by Our Dermatology Online.
ABSTRACT
Non-surgical facial rejuvenation has become a mainstay in aesthetic dermatology, offering effective, minimally invasive alternatives to traditional surgery. Techniques such as botulinum toxin injections, dermal fillers, energy-based devices, and regenerative therapies like platelet-rich plasma (PRP) are widely adopted. These procedures provide significant aesthetic improvements with reduced recovery times and fewer risks. Botulinum toxin remains the gold standard for dynamic wrinkle treatment, while hyaluronic acid fillers address volume loss and facial contouring. Energy-based devices—including lasers, radiofrequency, and ultrasound—enhance skin texture and elasticity. Regenerative approaches, especially PRP, show promise in cellular rejuvenation. Despite overall safety, complications such as vascular occlusion, burns, and hypersensitivity reactions underline the importance of proper technique and patient selection. This review highlights current practices, evidence-based outcomes, and safety considerations in non-surgical facial rejuvenation.
Key words: Non-surgical rejuvenation, Botulinum toxin, Dermal fillers, PRP, Laser therapy, Aesthetic dermatology, Safety
INTRODUCTION
Non-surgical facial rejuvenation techniques have transformed the field of aesthetic medicine over the past two decades. Driven by increased patient demand for safer, quicker, and less invasive options, these treatments aim to reverse the visible signs of aging—such as wrinkles, sagging, and volume loss—without the need for surgery [1]. Social media, aging populations, and advances in medical technology have all contributed to the mainstream popularity of aesthetic dermatologic procedures.
Modern rejuvenation strategies now include botulinum toxin injections, dermal fillers, fractional lasers, radiofrequency devices, and regenerative therapies such as PRP and exosomes. These methods offer impressive outcomes with minimal downtime and high patient satisfaction rates [2].
BOTULINUM TOXIN: EFFICACY AND SAFETY
Efficacy
Botulinum toxin type A is a neuromodulator that temporarily inhibits acetylcholine release at the neuromuscular junction, relaxing targeted facial muscles. It is most effective for dynamic wrinkles—particularly glabellar lines, forehead lines, and crow’s feet. Clinical results are typically seen within 3 to 7 days and can last up to 4 to 6 months [3].
Safety
Side effects are generally mild and include bruising, swelling, and headache. Rare adverse events such as eyelid ptosis or asymmetry occur if the toxin migrates beyond the target area. Long-term safety has been confirmed by repeated clinical use [4]. Careful dosing and proper injection technique minimize risks.
DERMAL FILLERS: VOLUME AND CONTOUR RESTORATION
Efficacy
Dermal fillers are widely used for volume restoration and contouring of the midface, lips, and jawline. Hyaluronic acid (HA)-based fillers are most common due to their biocompatibility, reversibility, and safety profile. Alternatives include calcium hydroxylapatite, poly-L-lactic acid, and polymethylmethacrylate [5]. Results can last from 6 to 18 months.
Safety
Most adverse events are transient: redness, swelling, and bruising. Vascular occlusion is the most serious risk and can result in tissue necrosis or blindness. Emergency reversal with hyaluronidase (in HA fillers) is critical in such cases [6]. High satisfaction is reported when administered by trained professionals.
ENERGY-BASED DEVICES: LASERS, RF, AND ULTRASOUND
Efficacy
Energy-based devices target deeper dermal layers to induce collagen production and skin tightening. Fractional CO2 and erbium lasers are used for resurfacing. Radiofrequency (e.g., Thermage®) and ultrasound (e.g., Ultherapy®) therapies stimulate neocollagenesis and improve laxity with minimal recovery time [7].
Safety
Risks include burns, hyperpigmentation, scarring, and discomfort. These are minimized by appropriate parameter selection and operator training [8].
REGENERATIVE THERAPIES: PRP AND EMERGING TREATMENTS
Platelet-Rich Plasma (PRP)
PRP therapy involves autologous blood centrifugation to concentrate platelets, which are rich in growth factors that promote tissue regeneration. It is used to improve skin texture, tone, and overall rejuvenation [9]. PRP is often combined with microneedling or lasers for synergistic results.
Other Innovations
Recent research highlights the potential of plant-derived compounds such as bakuchiol as retinoid alternatives, offering anti-aging benefits with fewer side effects [10].
COMBINATION THERAPIES
Multimodal approaches—such as combining botulinum toxin with fillers or using lasers alongside PRP—maximize results by targeting different aspects of the aging process. These combinations are individualized based on patient needs and provide more holistic outcomes [11].
COMPLICATIONS AND RISK MANAGEMENT
Though generally safe, complications may occur:
- Common: Bruising, swelling, transient asymmetry;
- Serious: Vascular occlusion, granuloma formation, device-related burns.
Risk Management Strategies:
- Patient Assessment: Detailed history, facial analysis;
- Informed Consent: Clear expectations, possible risks;
- Trained Practitioners: Certified injectors and operators;
- Emergency Preparedness: Access to hyaluronidase, protocol adherence;
- Aftercare: Patient education and follow-up.
CONCLUSION
Non-surgical facial rejuvenation continues to advance through innovation and interdisciplinary integration. Botulinum toxin, dermal fillers, energy devices, and regenerative therapies like PRP offer effective, patient-preferred alternatives to surgery. Combination treatments and evidence-based protocols are essential for safe, natural, and long-lasting outcomes. Continued education, careful patient selection, and adherence to safety guidelines are key to minimizing complications and optimizing satisfaction in modern aesthetic dermatology.
REFERENCES
1.Puri N. Platelet rich plasma in dermatology and aesthetic medicine. Our Dermatol Online. 2015;6:207-11.
2.Puri N. Is beauty skin deep –an approach to a beautiful face. Our Dermatol Online. 2014;5:301-3.
3.Kuśmierska M, Kuśmierski J, Martyka A, Ujma P. Redefining skin health:The potential of plant-based bakuchiol as a sustainable substitute for retinoids. Our Dermatol Online. 2024;15:345-8.
4.Puri N, Puri A. A comparative study on 100% TCA versus 88% phenol for the treatment of vitiligo. Our Dermatol Online. 2012;3:184-6.
5.Sharquie KE, Aljanabi WK. Infrared light heat therapy of port wine stain in adult patients as new innovative technique. Our Dermatol Online. 2021;12:e76.
6.Ahsan U, Uzair M, Aamir H. Comparison of safety and efficacy of 20% salicylic acid with Jessner’s solution in chemical peeling for melasma in Asian skin. Our Dermatol Online. 2021;12:e14.
7.Sobhy N, El-Shafaei A, Kamal N. Study of fractional ablative laser in surgical and post-traumatic scar. Our Dermatol Online. 2012;3:188-95.
8.Abreu Velez AM, Silver WE, Howard MS. Triple histology of an extracted polytef (gore-tex) implant. Our Dermatol Online. 2017;8:501-2.
9.Bukhari IA. Pulse dye laser therapy and superficial cryotherapy as a novel combination treatment for hypertrophic scars and keloids. Our Dermatol Online. 2022;13:28-31.
10.Ganjoo S, Vasani R, Gupta T. Urticarial eruption in COVID-19-positive children:A report of two cases. Our Dermatol Online. 2022;13:47-9.
11.Ajili F, Bousseta N, Msakni I, Metoui L, Gharsallah I, Laabidi J, et al. Symptomatic macroglossia and tongue myositis in dermatomyositis. Our Dermatol Online. 2013;4:176-8.
Notes
Copyright by authors of this article. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Request permissions
If you wish to reuse any or all of this article please use the e-mail (contact@odermatol.com) to contact with publisher.
| Related Articles | Search Authors in |
|
|
 http://orcid.org/0009-0009-9854-6944 |
Rights and permissions
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Comments are closed.